- Home
- Cardiology
- Triheptanoin in the Management of Cardiomyopathy in an Infant with VLCAD Deficiency: A Case Report
6d3 min read
Medical Article
Introduction: Long-chain fatty acid oxidation disorders (LC-FAODs) represent a group of autosomal recessive inborn errors of metabolism (1). LC-FAOD can cause cardiac hypertrophy and cardiomyopathy, often presenting in infancy and typically leading to death or heart transplant despite ongoing treatment (1). This case describes a female infant with

Triheptanoin in the Management of Cardiomyopathy in an Infant with VLCAD Deficiency: A Case Report
4 Reached
Similar Content

Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Patient with History of Atrial Fibrillation
519 Reached3 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes
